Results of delayed or salvage autologous hematopoietic stem cell transplantation for multiple myeloma
{{output}}
Autologous hematopoietic cell transplantation (autoHCT) remains a therapeutic option for multiple myeloma (MM) at relapse. We retrospectively analyzed 650 patients who underwent delayed (n = 335) or salvage (n = 315) autoHCT at a single center from 2006-2023. ... ...
